{{context|date=August 2014}}
{{ref improve|date=August 2014}}
{{Use dmy dates|date=November 2011}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459450489
| IUPAC_name = Sodium 7-ethyl-2-methyl-4-undecanyl sulfate
| image = Sodium 7-ethyl-2-methyl-4-undecanyl sulfate.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|sodium_tetradecyl_sulfate}}
| pregnancy_AU = <!-- A, B1, B2, B3, C, D, X -->
| pregnancy_US = <!-- A, B, C, D, X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled, S2, S3, S4, S5, S6, S7, S8, S9 -->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, Class A, B, C -->
| legal_US = <!-- OTC, Rx-only, Schedule I, II, III, IV, V -->
| legal_status = Prescription only
| routes_of_administration = Intravenous injection

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|CAS}}
| CAS_number = 139-88-8
| ATC_prefix = C05
| ATC_suffix = BB04
| PubChem = 14492
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = Q1SUG5KBD6
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200354
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 8440

<!--Chemical data-->
| C=14 | H=29 | Na=1 | O=4 | S=1 
| molecular_weight = 316.43243 g/mol
|  smiles = CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+]
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C14H30O4S.Na/c1-5-7-8-13(6-2)9-10-14(11-12(3)4)18-19(15,16)17;/h12-14H,5-11H2,1-4H3,(H,15,16,17);/q;+1/p-1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = FVEFRICMTUKAML-UHFFFAOYSA-M
| synonyms = 7-Ethyl-2-methyl-4-hendecanol sulfate sodium salt
}}

'''Sodium tetradecyl sulfate''' (STS) is a commonly used synonym for '''7-ethyl-2-methyl-4-undecanyl sulfate sodium salt'''<ref>{{cite web|url=http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm054378.pdf|accessdate=29 August 2014 | title = SOTRADECOLÂ® (Sodium tetradecyl sulfate)}}</ref> which is [[anionic]] [[surfactant]] that is the active component of the sclerosant drug '''Sotradecol'''. It is commonly used in the treatment of [[varicose vein|varicose]] and spider veins of the leg, during the procedure of [[sclerotherapy]]. Being a [[detergent]], its action is on the [[lipid]] molecules in the cells of the vein wall, causing inflammatory destruction of the internal lining of the vein and thrombus formation eventually leading to [[Sclerosis (medicine)|sclerosis]] of the vein. It is used in concentrations ranging from 0.1% to 3% for this purpose.
In the UK, Ireland, Italy, Australia, New Zealand and South Africa, it is sold under the trade-name Fibro-Vein in concentrations of 0.2%, 0.5%, 1.0%, and 3%.<ref>[http://www.fibro-vein.co.uk Fibro-Vein history and details]</ref>

==Synthesis==
It may be prepared by the [[aldol condensation]] of [[methyl isobutyl ketone]] and [[2-ethylhexanal]] (which is itself formed by the aldol self-concensation of [[butyraldehyde]]), followed by sulfonation of the resulting alcohol.

==References==
{{reflist}}


{{Vasoprotectives}}

[[Category:Organosulfates]]
[[Category:Organic sodium salts]]


{{cardiovascular-drug-stub}}